We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$402M
AUM Growth
+$154M
Cap. Flow
+$140M
Cap. Flow %
34.96%
Top 10 Hldgs %
34.66%
Holding
133
New
31
Increased
71
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$5.69M
2
MA icon
Mastercard
MA
+$5.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$4.68M
4
CNI icon
Canadian National Railway
CNI
+$4.64M
5
NVS icon
Novartis
NVS
+$4.59M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.02M
2
XEC
CIMAREX ENERGY CO
XEC
+$214K
3
HUB.B
HUBBELL INC CL-B
HUB.B
+$202K
4
GLW icon
Corning
GLW
+$152K
5
GILD icon
Gilead Sciences
GILD
+$20.7K

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Healthcare 21.83%
3 Industrials 18.28%
4 Energy 9.56%
5 Consumer Staples 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRGO icon
26
Perrigo
PRGO
$1.4B
$5.88M 1.46%
35,150
+18,613
+113% +$2.91M
ABT icon
27
Abbott
ABT
$182B
$5.84M 1.45%
129,630
+55,665
+75% +$2.42M
NXPI icon
28
NXP Semiconductors
NXPI
$67.6B
$5.64M 1.4%
73,770
+30,330
+70% +$2.15M
CSCO icon
29
Cisco
CSCO
$452B
$5.12M 1.28%
184,188
+49,420
+37% +$1.28M
HP icon
30
Helmerich & Payne
HP
$3.36B
$4.53M 1.13%
67,208
+30,197
+82% +$2.35M
TGT icon
31
Target
TGT
$63.7B
$4.5M 1.12%
59,324
+30,465
+106% +$2.06M
IPGP icon
32
IPG Photonics
IPGP
$3.81B
$4.45M 1.11%
59,425
+37,160
+167% +$2.64M
PBA icon
33
Pembina Pipeline
PBA
$29B
$4.38M 1.09%
120,425
+53,015
+79% +$2.01M
STT icon
34
State Street
STT
$50.7B
$3.35M 0.83%
42,679
+28,746
+206% +$2.16M
ABB
35
DELISTED
ABB Ltd
ABB
$3.29M 0.82%
155,570
+44,809
+40% +$970K
GE icon
36
GE Aerospace
GE
$375B
$3.09M 0.77%
25,541
-71
-0.3% -$8.73K
ILMN icon
37
Illumina
ILMN
$28.7B
$2.58M 0.64%
14,357
+10,756
+299% +$1.9M
XLNX
38
DELISTED
Xilinx Inc
XLNX
$2.54M 0.63%
58,730
+23,165
+65% +$1M
IBM icon
39
IBM
IBM
$204B
$2.4M 0.6%
15,645
+771
+5% +$123K
MRK icon
40
Merck
MRK
$323B
$2.1M 0.52%
38,754
+6,348
+20% +$354K
XYL icon
41
Xylem
XYL
$28.6B
$1.91M 0.48%
50,198
+25,945
+107% +$949K
CDK
42
DELISTED
CDK Global, Inc.
CDK
$1.89M 0.47%
+46,231
New +$1.64M
UNP icon
43
Union Pacific
UNP
$178B
$1.75M 0.44%
14,716
+720
+5% +$82.7K
ABBV icon
44
AbbVie
ABBV
$454B
$1.74M 0.43%
26,600
+960
+4% +$60.5K
LH icon
45
Labcorp
LH
$24.7B
$1.73M 0.43%
18,694
+13,561
+264% +$1.2M
CL icon
46
Colgate-Palmolive
CL
$73.6B
$1.67M 0.41%
24,062
+4,450
+23% +$301K
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$1.67M 0.41%
+8,100
New +$1.63M
GIS icon
48
General Mills
GIS
$19.5B
$1.62M 0.4%
30,423
+5,085
+20% +$263K
DE icon
49
Deere & Co
DE
$169B
$1.55M 0.38%
17,475
+1,100
+7% +$95K
IONS icon
50
Ionis Pharmaceuticals
IONS
$9.25B
$1.52M 0.38%
24,662
+14,557
+144% +$718K
1
2
3 4 5

Similar funds

NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $379M AUM 21.34% 1-Year Est. Return
MLFP
MPS Loria Financial Planners Burr Ridge, Illinois $379M AUM 17.57% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $379M AUM 24.17% 1-Year Est. Return
AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM

Kurt F. Somerville's Q4 2014 Portfolio in Review

As of Q4 2014, Kurt F. Somerville held 133 positions worth $402M, up 62% from $248M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kurt F. Somerville deployed $140M of net new capital in Q4 2014, opening 31 new positions and adding to 71 existing holdings. Its largest new stake was CDK Global, Inc.: 46,231 shares worth $1.89M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was GSK, an estimated $1.02M trimmed.

  • Kurt F. Somerville's largest Q4 2014 buy was CDK Global, Inc.: 46,231 shares worth $1.89M.
  • Kurt F. Somerville added most to CVS Health in Q4 2014, an estimated $5.69M increase.
  • Kurt F. Somerville's biggest Q4 2014 reduction was GSK, cutting an estimated $1.02M.
  • Kurt F. Somerville fully exited CIMAREX ENERGY CO in Q4 2014, selling an estimated $214K.
  • Kurt F. Somerville's ten largest holdings make up 35% of its $402M portfolio in Q4 2014.
  • Kurt F. Somerville opened 31 new positions and closed 3 in Q4 2014.
  • Kurt F. Somerville's portfolio value rose 62% quarter-over-quarter to $402M.

Based on Kurt F. Somerville's 13F filing for Q4 2014, filed 13 Feb 2015.